Marinus Pharmaceuticals Inc (STU:61Y)
€ 0.292 0.076 (35.19%) Market Cap: 19.67 Mil Enterprise Value: 32.91 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 36/100

Marinus Pharmaceuticals Inc Investor and Analyst Event Transcript

Sep 19, 2023 / 01:00PM GMT
Release Date Price: €6.45 (+17.27%)
Sonya Weigle
Marinus Pharmaceuticals, Inc. - Senior VP of IR, HR & Corporate Affairs

All right. Good morning, everybody. It's nice to see you all here in person. Welcome to the Marinus Pharmaceuticals 2023 Investor and Analyst Event. We're super excited about this because this is our first in-person event to do something like this, and so it's super exciting.

And I just want to extend additionally a really warm welcome to everybody that's joining us on the webcast. My name is Sonya Weigle and I'm the Senior Vice President of Investor Relations, Human Resources and Corporate Affairs at Marinus. I also want to introduce our newest colleague, the IR team, Jim DeNike, our Senior Director of Investor Relations.

Welcome, Jim. So today, I'm pleased to introduce today's speakers to share our agenda and to make some opening remarks. Before we begin, I'd just like to remind everyone -- but some of the statements made today are forward-looking statements under the securities laws. These forward-looking statements include substantial risks and uncertainties that could cause our clinical

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot